Tyler R. McCaw
-
- Peptidase Inhibition and Analysis 2
-
- Immune Cell Function and Interaction 3
-
- Histone Deacetylase Inhibitors Research 5
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
-
- Health and Medical Research Impacts 2
- Innovations in Medical Education 2
-
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Troy D. RandallDonald J. BuchsbaumAndres ForeroRebecca C. ArendHerbert ChenJ. Bart RoseBin RenJames Bibb
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Cancer Immunology Immunotherapy (2 papers)Cancer (1 paper)Journal of Investigative Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Tyler R. McCaw
13 papers receiving 315 citations
Peers
Comparison fields: 5 of 59
- Oncology 125
- Immunology 82
- Molecular Biology 153
- Cancer Research 21
- Physiology 6
Countries citing papers authored by Tyler R. McCaw
This map shows the geographic impact of Tyler R. McCaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler R. McCaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler R. McCaw more than expected).
Fields of papers citing papers by Tyler R. McCaw
This network shows the impact of papers produced by Tyler R. McCaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler R. McCaw. The network helps show where Tyler R. McCaw may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tyler R. McCaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 86 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 18 | |
| 12 | 2019 | 35 | |
| 13 | 2018 | 8 | |
| 14 | 2018 | 29 | |
| 15 | 2018 | 24 | |
| 16 | 2017 | 31 | |
| 17 | 2017 | 37 | |
| 18 | 2014 | 20 |
About Tyler R. McCaw
Tyler R. McCaw is a scholar working on Oncology, Immunology and Molecular Biology, having authored 18 papers that have together received 317 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Immune Cell Function and Interaction (3 papers), Epigenetics and DNA Methylation (2 papers), Health and Medical Research Impacts (2 papers), Protein Degradation and Inhibitors (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers) and Innovations in Medical Education (2 papers). The work is most often cited by research in Oncology (125 citations), Immunology (82 citations) and Molecular Biology (153 citations). Tyler R. McCaw has collaborated with scholars based in United States. Frequent co-authors include Troy D. Randall, Donald J. Buchsbaum, Andres Forero, Rebecca C. Arend, Herbert Chen, J. Bart Rose, Bin Ren, James Bibb, Renata Jaskula‐Sztul and Vikas Dudeja. Their work appears in journals such as Cancer Immunology Immunotherapy, Cancer, Journal of Investigative Medicine, Infectious Diseases and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.